If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,396.00    -2.00 (-0.14%)
Bid:
1,392.00
Ask:
1,410.00
Spread: 18.00 (1.293%)
Market Cap: £639.79m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Director/PDMR Shareholding

14 Aug 2014 09:30

RNS Number : 1263P
Cohort PLC
14 August 2014
 



14 August 2014

COHORT PLC (the "Company")

Director Shareholdings, Share Awards and Options

Cohort plc (the "Company") wishes to notify the following changes in the interests of directors of the Company in ordinary shares of 10 pence in relation to share awards and share options.

Director shareholdings

Yesterday, the Company was notified that the sale of shares to satisfy share option exercise costs took place on 12 August 2014 as follows:

Description

Ordinary Shares

Market Value(pence)

Sale by AS Thomis' wife

25,477

197.25 p

Sale by SR Walther

7,644

197.25 p

Sale by SR Walther's wife

7,643

197.25 p

Following all transactions to date, including those detailed below, and subject to the completion of ISA transfers announced on 5 August 2014, Mr Thomis' and Mr Walther's interests and that of their connected persons are as follows:

Director

Ordinary shares

% of the total issued share capital

AS Thomis

86,225

0.21

SR Walther

78,892

0.19

Grant of Share Awards

On 11 August 2014 share awards pursuant to the 2013 Restricted Share Scheme established on 30 July 2013 ("Restricted Share Scheme") were granted to directors of the Company for nil consideration as follows:

Director

Number of sharesunder this award

Total number of unvested shares under the Restricted Share Scheme following grant

AS Thomis

19,342

20,556

SR Walther

15,595

17,196

Full beneficial ownership of Restricted Shares (including voting and dividend rights) will transfer to the recipients in stages over a three-year period from the date of grant. Recipients may only sell Restricted Shares with the approval of the Chairman of the Remuneration & Appointments Committee while they remain in employment with the Company. Further details regarding the Restricted Shares can be found in the Company's Annual Report and Accounts 2014.

Grant of Share Options

On 11 August 2014 share options pursuant to the Cohort plc 2006 Share Option Scheme ("Unapproved") and the Approved Share Option Subplan ("Approved") were granted to directors of the Company as follows:

Director

Number of shares under this option

Exercise Price(pence)

Total number of shares under option following grant

AS Thomis - Unapproved

4,153

197.5

246,944

Approved

15,189

197.5

15,189

SR Walther - Unapproved

406

197.5

172,580

Approved

15,189

197.5

15,189

The options can be exercised between 12 August 2017 and 11 August 2024.

On 11 August 2014 share options pursuant to the Cohort plc Savings Related Share Option Scheme ("SAYE Scheme") were granted to directors of the Company as follows:

Director

Number of shares underthis option

Exercise Price (pence)

Total number of shares under the SAYE Scheme following grant

AS Thomis

2,602

207.5

4,932

SR Walther

867

207.5

6,692

The options are made pursuant to three year savings contracts.

The total share options held under each scheme following grant as set out above includes the recent exercise of share options announced on 5 August 2014.

Ends

For further information, please contact

Cohort plc

Andrew Thomis, Chief ExecutiveSimon Walther, Finance Director

+44 (0)118 909 0390

Investec

Keith Anderson, Daniel Adams

+44 (0)20 7597 5970

MHP Communications

Reg Hoare, Vicky Watkins

+44 (0)20 3128 8100

Cohort plc

Cohort is an independent technology group working primarily for defence (air, land and sea), wider government and industry clients, through four market-facing subsidiary companies:

MASS - a specialist systems house with considerable experience in the defence market and a focus on electronic warfare operational support and secure information systems. Based in Cambridgeshire, MASS was acquired by Cohort in August 2006;

MCL - an expert in electronic and surveillance technology design and manufacturing, product and in the field support and training for a range of specialist UK end users, including the MOD and other governmental agencies. Based in Surrey, MCL has been part of the Group since July 2014;

SCS - a defence technical advisory business, combining technical expertise with practical experience and domain knowledge. Owned by Cohort since flotation in March 2006;

SEA - an advanced surveillance systems and software house with hardware development capability operating in the defence and transport market sectors. Acquired by Cohort in October 2007.

Cohort was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Berkshire and employs in total around 500 core staff there and at its other operating company sites in Bristol, Cambridgeshire, Lincolnshire, Somerset and Surrey.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGIGDIGXBBGSS
Date   Source Headline
24th Feb 20231:25 pmRNSBlock listing Interim Review
17th Feb 202310:13 amRNSDirector/PDMR Shareholding
15th Feb 202310:30 amRNSDirector/PDMR Shareholding
1st Feb 20239:42 amRNSTotal Voting Rights
27th Jan 20233:30 pmRNSEBT Purchase of Shares
20th Jan 20237:00 amRNSInvestor Presentation
16th Jan 20237:00 amRNSInterim Report 2022
3rd Jan 20234:00 pmRNSEBT Purchase of Shares
3rd Jan 20233:30 pmRNSTotal Voting Rights
22nd Dec 20225:14 pmRNSEBT Purchase of Shares
14th Dec 20224:51 pmRNSHolding(s) in Company
14th Dec 20227:00 amRNSHalf Year Results
5th Dec 202211:30 amRNSNotice of Results
30th Nov 20224:41 pmRNSSecond Price Monitoring Extn
30th Nov 20224:36 pmRNSPrice Monitoring Extension
30th Nov 20223:18 pmRNSTotal Voting Rights
24th Nov 20227:00 amRNSMASS awarded contract extension
31st Oct 20224:50 pmRNSTotal Voting Rights
21st Oct 20224:40 pmRNSDirector/PDMR Shareholding
21st Oct 20229:44 amRNSDirector/PDMR Shareholding
11th Oct 20222:15 pmRNSDirector/PDMR Shareholding
5th Oct 20224:46 pmRNSBLOCK LISTING SIX MONTHLY RETURN
30th Sep 202211:04 amRNSTotal Voting Rights
29th Sep 20225:18 pmRNSDirector/PDMR Shareholding
28th Sep 20227:00 amRNSResult of AGM
27th Sep 20227:00 amRNSAGM Statement and First Quarter Update
8th Sep 20227:00 amRNSDirector/PDMR Shareholding
7th Sep 20227:00 amRNSSEA AWARDED UPGRADE CONTRACT WITH MOD
31st Aug 20222:15 pmRNSTotal Voting Rights
25th Aug 20227:00 amRNSAnnual Report and Notice of Annual General Meeting
24th Aug 20229:30 amRNSBlock listing Interim Review
12th Aug 202210:04 amRNSDirector Share Awards and Shareholdings
11th Aug 202212:06 pmRNSTransfer of Shares
10th Aug 20222:59 pmRNSDirector/PDMR Shareholding
29th Jul 202212:40 pmRNSTotal Voting Rights
28th Jul 20227:00 amRNSDirectorate Change
28th Jul 20227:00 amRNSPreliminary Results
26th Jul 202210:35 amRNSNotice of Results
25th Jul 20221:17 pmRNSHolding(s) in Company
19th Jul 20224:10 pmRNSHolding(s) in Company
19th Jul 20227:00 amRNSCohort plc extends banking facility
30th Jun 20223:21 pmRNSTotal Voting Rights
31st May 20221:31 pmRNSTotal Voting Rights
26th May 20227:00 amRNSFull Year Trading Update
29th Apr 20224:15 pmRNSTotal Voting Rights
25th Apr 20227:00 amRNSHolding(s) in Company
22nd Apr 20223:35 pmRNSDirector/PDMR Shareholding
13th Apr 20227:00 amRNSDirector/PDMR Shareholding
4th Apr 20223:00 pmRNSBlock listing Interim Review
1st Apr 20227:00 amRNSContract Win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.